Title: Clinicomorphological and Immunohistochemical Profile of Lung Carcinoma Specimens Received at a Tertiary Care Centre

Authors: Himanshi Diwan, Ajay Yadav, Jayanti Mehta

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i6.50

Abstract

Introduction: Lung cancer is the major cause of mortality worldwide and its incidence is rising in India. Sub classifying non small cell carcinoma is vital for prognosis and treatment of the patients. Several immunohistochemical markers have been studied to serve this purpose.  In small samples, TTF-1 and p63 are sufficient to further classify the non small cell lung carcinoma. The present study aimed to study morphology and imunohistochemical profile of various lung carcinoma.

Methods: A total of 65 cases of lung carcinoma were studied in a span of 18 months. All benign conditions were excluded from the study. Hematoxylin and eosin stained sections were studied and immunohistochemical panel was applied on the selected cases.

Results: 54 cases were of non small cell lung carcinoma, 10 were of neuroendocrine tumours and 1 was a rare case of pulmonary blastoma. Maximum cases were found to be in the age group of 51-60 years. Squamous cell carcinoma constituted 47.69% of cases followed by adenocarcinoma accounting for 32.30% of cases. TTF-1 was 88.89% sensitive in detecting adenocarcinoma and p63 was positive in 80% of squamous cell carcinoma. Chromogranin was 88.88% sensitive for neuroendocrine tumours.

Discussion: TTF-1, p63, CK7, CK5/6 help in differentiating poorly differentiated tumours and hence serve as a prognostic marker in lung carcinomas.

Keywords: Lung carcinoma, immunohistochemistry, targeted therapy.

References

1.      National Council Registry Programme-3 year report of population based cancer registries : 2009-2011.Indian Council of Medical Research;2013.available from http://www.ncrpindia.org

2.      Ladanyil Marc, Pao William.Lung adenocarcinoma:guiding EGFR targeted therapy and beyond.Modern Pathology. 2008;21:116-22

3.      Husain Aliya N. The lung: Tumours. In: Kumar, Abbas,Aster(Eds).Robbins and Cotran Pathologic basis of disease: 9th ed.Elsevier; 2015

4.      Juan Rosai. The Lung and pleura. In: Juan Rosai(Eds).Rosai and Ackerman’s surgical Pathology. 10th ed.Elsevier; 2011

5.      Masayuki Noguchi, Yukio Shimosato. Pulmonary neoplasms. In: Stacey E., Mills(Eds.).Sternbergs Diagnostic Surgical Pathology. 6th ed.Wolters Kluwer Health; 2015.

6.      Ronald G. Vincent, john N. Pickren, Warren W. Lane, Irwin Bross, Hiroshi Takita,Loren Houten et al.The changing histopathology of lung cancer-A review of 1682 cases.Cancer 2006;39:1647-55

7.      Behera D,Balamugesh T.Lung cancer in India.Indian J Chest Dis Allied Sci.2004;46 :269-81

8.      Singh N,Aggarwal AN, Gupta D,behera D, Jindal SK.Unchanging clinicoepidem-iological profile of lung cancer in North India ovr three decades.Cancer Epidemiol.2010;34;101-4

9.      Noronha V,Dikshit R, Rant N, Joshi A, Pramesh CS, George K,et al. Epidemiology of lung cancer in India : focus on the differences between non- smokers and smokers : asingle centre experience. Indian JCancer.2012;49:74-81

10.  Malik PS, Sharma MC,Mohanti BV, Shukla NK, Deos ,Mohan A , et al. Clinicopathological profile of lung cancer at AIIMS : A changing paradigm in India . Asian Pacific J Cancer Prev, 14 (1),489-94 DOI:http://dx.doi.org/10.7314/APJCP.2013.14.1.489.

11.  Rawat J,Sindhwani G,Gaur D,Dua R, Saini S.Clinicopathological profile of lung cancer in Uttarakhand.Lung India.2009;26:74-6

12.  Wei Zhao, Hui Wang ,Yan Peng ,Bo Tian ,Lei Peng , Da-Chuan Zhang. ∆Np63, CK5/6, TTF-1 and Napsin A,a reliable panle to subtype non-small cell lung cancer in biopsy specimens , Int J Clin Exp Pathol.2014;7(7):4247-53

13.  Mukhopadhyay S, Katzenstein AL.Subclassification of non small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1 , napsin A,p63,ck5/6.Am J Surg Pathol.2011;35:15-25

14.  Jefferson Terry,Samuel Leung ,Janessa Laskin ,Kevin O. Leslie, Allen M. Gown and  Diana N. Ionescu . Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.Am J Surg Pathol.2010;34:1805-1811

15.  E Lim, P. Goldstraw, A.G. Nicholson et al. Proceedings of the IASLC international workshop on advances in pulmonary neuroendocrine tumours 2007. J Thorac Oncol.2008;123(6):1194-1201

16.                        Shankar Shanmugapriya , Thanasekaran Vijaylakshmi, Dhanasekar T and Duvooru Prathibha . Clinicopathological and immunohistochemical profile of non small cell lung carcinoma in a tertiary care medical centre in South India. Lung India .2014;31(1):23-28

Corresponding Author

Himanshi Diwan

R-85 First Floor, Model Town- 3 Delhi.110009

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.